Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.
Lía Nattero-Chavez, Terezie Pelikanova, Zdenek Sumnik, Marcus Lind, Christoph Nowak, Elena Lundberg, Ana Gómez-Gila, Johnny Ludvigsson, Rosaura Casas, Ulf Hannelius, Sara Puente-Marin, Fabricia Dietrich, Stepanka Pruhova, Theo Sas, Marta Ferrer Lozano, Maria Clemente-León, Cristina Hernandez, Ragnar Hanas, Jeanette Wahlberg, MariSol Ruiz de Adana, Maria A Martínez-Brocca, Itxaso Rica
The Journal of clinical endocrinology and metabolism 2022;107(9):2644-2651